Nomi Nanami, Ota Manami, Fukumura Miho, Nuno Yoshihisa, Hatano Makoto, Wakuta Makiko, Yanai Ryoji, Kimura Kazuhiro
Japan Community Health Care Organization (JCHO) Shimonoseki Medical Center, Shimonoseki, Yamaguchi, Japan.
JA Shuto General Hospital, Yanai, Yamaguchi, Japan.
Jpn J Ophthalmol. 2018 Mar;62(2):163-167. doi: 10.1007/s10384-017-0552-7. Epub 2017 Dec 21.
To report 2 cases of paclitaxel-related maculopathy manifesting as cystoid macular edema (CME) with late petaloid hyperfluorescence on indocyanine green angiography (IA).
A 74-year-old man (patient 1) undergoing paclitaxel chemotherapy for gastric and metastatic liver cancer and a 69-year-old man (patient 2) receiving paclitaxel for hypopharyngeal cancer presented with anorthopia in both eyes. Spectral domain-optical coherence tomography (SD-OCT) revealed macular edema in both eyes of each patient. Fluorescein angiography showed weak petaloid pooling around the fovea in the late phase. IA revealed CME with petaloid hyperfluorescence that matched the region of macular edema detected by SD-OCT. The CME was attenuated in the right eye but not in the left eye of patient 1 at 2 weeks after discontinuation of paclitaxel treatment, whereas it was no longer apparent in either eye at 3 months. The CME was no longer detected in either eye of patient 2 at 3 months after discontinuation of paclitaxel.
These cases suggest that paclitaxel-induced CME may result from intraretinal accumulation of intracellular fluid and minimal impairment of the blood retinal barrier.
报告2例紫杉醇相关黄斑病变,表现为黄斑囊样水肿(CME),吲哚菁绿血管造影(IA)显示晚期花瓣样高荧光。
1例74岁男性(患者1)因胃癌和转移性肝癌接受紫杉醇化疗,1例69岁男性(患者2)因下咽癌接受紫杉醇治疗,均出现双眼视物不正。频域光学相干断层扫描(SD-OCT)显示每名患者双眼均有黄斑水肿。荧光素血管造影显示晚期在黄斑中心凹周围有微弱的花瓣样荧光素渗漏。IA显示CME伴有花瓣样高荧光,与SD-OCT检测到的黄斑水肿区域相符。紫杉醇治疗中断2周后,患者1右眼的CME减轻,但左眼未减轻,而在3个月时双眼CME均不再明显。紫杉醇治疗中断3个月后,患者2双眼均未再检测到CME。
这些病例提示,紫杉醇诱导的CME可能是由于细胞内液在视网膜内积聚以及血视网膜屏障轻度受损所致。